These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7371772)

  • 1. Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.
    Bertolini A; Castelli M; Genedani S; Garuti M
    Experientia; 1980 Feb; 36(2):243-4. PubMed ID: 7371772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
    de Rautlin de la Roy Y; Toma V; Bobin B
    Curr Med Res Opin; 1978; 5(9):743-8. PubMed ID: 738079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
    Greenwood D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro action of oxolinic acid in comparison with nitrofurantoin and nalidixic acid].
    Grima P
    Minerva Urol; 1977; 29(5):225-7. PubMed ID: 611403
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of antibacterial activity of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon) in vitro and in patients with urinary tract infections].
    Manitius A; Hebanowski M; Galiński J; Nowicki B
    Pol Tyg Lek; 1978 Aug; 33(34):1347-50. PubMed ID: 704439
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D; Pennucci C; Esposito S; Galante D
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.
    Gilis PM; Haemers A; Pattyn SR
    Antimicrob Agents Chemother; 1978 Mar; 13(3):533-5. PubMed ID: 263890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Minimal inhibitory concentration in hospital bacteria].
    Marcenac FM; Fernández AJ; Rebollo MN; Helou HT; Civalero TR; Herran IL; Magri MA
    Rev Asoc Argent Microbiol; 1974; 6(2):44-61. PubMed ID: 4467221
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of six quinolone antibacterials (author's transl)].
    Soussy CJ; Thibault M; Kitzis MD; Acar JF; Duval J; Chabbert YA
    Ann Microbiol (Paris); 1977 Jul; 128B(1):19-33. PubMed ID: 907268
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Oxolinic acid in urinary infections.
    Grüneberg RN
    Lancet; 1974 Nov; 2(7888):1088-9. PubMed ID: 4138360
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.
    Gordon RC; Stevens LI; Edmiston CE; Mohan K
    Antimicrob Agents Chemother; 1976 Dec; 10(6):918-20. PubMed ID: 12717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of miloxacin.
    Izawa A; Kisaki Y; Irie K; Eda Y; Nakagome T; Komatsu T
    Antimicrob Agents Chemother; 1980 Jul; 18(1):37-40. PubMed ID: 7416749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the antibacterial effects of ofloxacin, oxolinic acid and nalidixic acid].
    Langsádl L; Menkyna R; Golier J; Silan L
    Cesk Epidemiol Mikrobiol Imunol; 1988 Sep; 37(5):297-308. PubMed ID: 3197127
    [No Abstract]   [Full Text] [Related]  

  • 15. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.
    Gellert M; Mizuuchi K; O'Dea MH; Itoh T; Tomizawa JI
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4772-6. PubMed ID: 337300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies of the effect of oxolinic and nalidixic acids on urinary flora].
    Balog F; Këvesh SH; Kochish B
    Urol Nefrol (Mosk); 1974; (6):25-8. PubMed ID: 4446181
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial resistance of Shigellae isolated in Michigan.
    Gordon RC; Thompson TR; Carlson W; Dyke JW; Stevens LI
    JAMA; 1975 Mar; 231(11):1159-61. PubMed ID: 1089819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparison of the effects of three urinary infection chemotherapeutics - nalidixic, oxolinic, and pipemidic acids (author's transl)].
    Langsádl L; Polívková-Konícková L; Roubínek F
    Cas Lek Cesk; 1979 May; 118(19):588-92. PubMed ID: 498218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Variations in vitro of the efficacy of quinolones as a function of pH].
    François B; Gille Y; Schmuck N; Assenat H; Adeleine P; Davoine P
    Nephrologie; 1983; 4(6):259-62. PubMed ID: 6669186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.